Peter Kaspar

Sloning BioTechnology specializes in the production of highly genetically diverse and precise customized libraries. The company offers high quality, innovative, tailored protein engineering solutions to its industrial and biopharmaceutical customers worldwide. As a business specializing in the development and production of genetically diverse libraries, Sloning BioTechnology GmbH offers high quality, innovative, tailored protein engineering solutions to its industrial and biopharmaceutical customers worldwide. The firm's Slonomics core technology is a unique DNA engineering platform that uses defined sets of double stranded DNA triplets to precisely introduce the required mutations into any DNA sequence. This multiply validated technology takes a novel approach to enable the realization of highly complex design concepts while at the same time ensuring that libraries generated by Sloning have the very highest standards of reliability. It harnesses the capabilities of Slonomics to synthesize SlonoMax and SlonoMax libraries are customized mutant libraries that significantly improve the efficiency of screening for new and improved proteins for therapeutic, enzymatic or technical applications. In addition, it offers a premium gene synthesis service using Slonomics for its industrial clients. SlonoGene is a tailored service offering gene customization and optimization suited perfectly to the needs of its customers.

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.

Daktari Diagnostics, Inc. operates as a holding company that provides healthcare solutions. The firm engages in the development of point-of-care diagnostic systems for global health applications. Its product includes Daktari Virology which detects HIV and HCV, Daktari InSight which provides data management services, and Daktari Sickle Cell which detects sickle cell disease on infants. The company was founded by William Rodriguez in 2008 and is headquartered in Cambridge, MA.

Immunodiagnostic Systems Holdings Plc engages in the development, manufacture, and marketing of in-vitro diagnostic tests (IVD) to the clinical laboratory market. The company was founded in 1977 and is headquartered in Boldon, the United Kingdom.

First Light Diagnostics, Inc. develops automated medical diagnostic products for the detection of microbes that cause healthcare and hospital infections. The firm offers MultiPath technology detects and counts fluorescent targets without using magnification. Its MultiPath technology is used for screening, blood infections, surgical infections, skin infections and GI infections. The company was founded by Donald Straus and is headquartered in Bedford, MA.